Work

Trends and Innovations in Peptide Drug Discovery: A Century of Progress and Future Directions

Year: 2024
Type: article
Abstract: Peptide drug discovery has revolutionized modern therapeutics, offering novel treatment avenues for various diseases, including cancer, metabolic disorders, and infectious diseases. Over the past century, advancements in synthesis techniques, such as solid-phase peptide synthesis and recombinant technology, have significantly enhanced the development and scalability of peptide-based drugs. Emerging innovations, including machine learning-driven screening, phage display, and combinatorial chemistry, have accelerated the identification of bioactive peptides with high specificity and efficacy. Additionally, chemical modifications such as PEGylation, cyclization, and unnatural amino acid incorporation have improved the stability, bioavailability, and half-life of peptide drugs. The integration of nanotechnology and venomics has further expanded the potential of peptide therapeutics by enabling targeted drug delivery and enhancing pharmacokinetic properties. Despite these advancements, challenges such as enzymatic degradation and poor oral bioavailability remain key obstacles. However, ongoing research in novel drug delivery systems, including lipidation, nanocarriers, and AI-driven peptide design, is addressing these limitations. With the global peptide therapeutics market experiencing substantial growth, driven by increasing prevalence of chronic diseases and aging populations, peptides are emerging as a dominant class of pharmaceuticals. This review highlights the recent trends, technological breakthroughs, and future prospects in peptide drug discovery, underscoring its transformative impact on modern medicine.
Language: English
Field: Chemistry
Open Access status: diamond
OpenAlex ID: W7217322649
FWCI:
Cites:
Cited by:
Related to: 10